22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
You already know that ERISA regulations set specific timelines for the issuance of ERISA-governed lo...
Read More >
A recent opinion issued by a trial court in New York, Rad and D’Aprile, Inc. v. Arnell Construction...
Read More >
Following the release of the second round of Paycheck Protection Program (PPP) funding, the Small Bu...
Read More >
In response to the lawsuit filed against the City of San Antonio regarding its paid sick leave ordin...
Read More >
Minimum Age for Continued Unemployment Allowance Rises - New Legislation Enacted - The minimum age...
Read More >
The 359-page emergency Coronavirus Bill received royal assent on 25 March 2020. This newly passed Co...
Read More >